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abstractBACKGROUND AND OBJECTIVE: Increasing data suggest that neonatal pain has long-term consequences.
Nonpharmacologic techniques (sucrose taste, pacifier suckling, breastfeeding) are effective
and now widely used to combat minor neonatal pain. This study examined the analgesic effect
of sucrose combined with radiant warmth compared with the taste of sucrose alone during
a painful procedure in healthy full-term newborns.
METHODS: A randomized, controlled trial included 29 healthy, full-term newborns born at the
University of Chicago Hospital. Both groups of infants were given 1.0 mL of 25% sucrose
solution 2 minutes before the vaccination, and 1 group additionally was given radiant warmth
from an infant warmer before the vaccination. We assessed pain by comparing differences in
cry, grimace, heart rate variability (ie, respiratory sinus arrhythmia), and heart rate between
the groups.
RESULTS: The sucrose plus warmer group cried and grimaced for 50% less time after the
vaccination than the sucrose alone group (P , .05, respectively). The sucrose plus warmer
group had lower heart rate and heart rate variability (ie, respiratory sinus arrhythmia)
responses compared with the sucrose alone group (P , .01), reflecting a greater ability to
physiologically regulate in response to the painful vaccination.
CONCLUSIONS: The combination of sucrose and radiant warmth is an effective analgesic
in newborns and reduces pain better than sucrose alone. The ready availability of
this practical nonpharmacologic technique has the potential to reduce the burden of
newborn pain.
WHAT’S KNOWN ON THIS SUBJECT: Increasing
data suggest that neonatal pain has long-term
consequences. Pharmacologic interventions for
minor pain are ineffective, and
nonpharmacologic techniques (sucrose taste,
pacifier suckling, breastfeeding) are effective
and now widely used.
WHAT THIS STUDY ADDS: The taste of sucrose
has been shown to be an effective and widely
used analgesic for infants, and this study
demonstrates that combining brief exposure to
natural radiant warmth with the taste of sucrose
improves the analgesic effect for the infant.
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Healthy newborns undergo many
minor painful procedures, such as
heel lance for newborn screenings,
blood draws, and immunizations.
Newborns may not have the pain-
modulating mechanisms that function
in older children and adults, and they
may be more sensitive to pain.1 The
short-term effects of painful
procedures include crying or
grimacing, disturbance in sleep or
wakefulness state, increased oxygen
consumption, ventilation–perfusion
mismatch, and increased gastric
acidity.2–4 The long-term effects may
be an exaggerated response to pain in
later infancy5 and the neurotoxicity of
untreated pain in the developing
brain.6
Strong pharmacologic interventions
are rarely used during short, minor
painful procedures in neonates
because of the risk of adverse effects
on the newborn’s respiratory and
central nervous systems. Studies
evaluating pharmacologic agents such
as morphine demonstrate reduced
behavioral and hormonal stress
responses during surgery in term
infants7–9; morphine’s analgesic
effect on acute pain caused by minor
procedures is less effective.10 Topical
anesthetics such as Eutectic Mixture
of Local Anesthetics are available for
minor pain procedures, but
systematic review suggests topical
anesthetics are less effective in
infants and young children11 and
have not been recommended for
minor pain caused by heel sticks in
infants.12
Recent systematic reviews indicate
that sweet taste is effective for
reducing behavioral indicators of
pain in infants #1 year of age during
common minor procedures including






wide use, there is concern about
repeated use of sucrose in this
population.3,17,18 Asmerom et al2
reported that a single dose of
sucrose for heel lance in preterm
infants decreases the behavioral
indicators of pain but increases
physiologic markers of oxidative
stress and heart rate. Although using
sucrose use is safe,19–23 it does not
prevent later exaggerated pain
response,24,25 and its mechanism of
action is not fully understood.26,27
Finally, the evidence is inconclusive
on whether multiple doses of
sucrose may alter later development.
Preterm infants (,31 weeks’
estimated gestational age) who
received sucrose for all painful
procedures during their first 7 days
had lower neurodevelopmental
scores at term,18 particularly if they
received .10 doses per day.28
However, a similar detrimental
neurodevelopmental effect was not
found in preterm infants (,30
weeks’ estimated gestational age)
who had sucrose for all painful
procedures during their first 28 days
of life.29
In the hospital setting,
nonpharmacologic interventions have
become increasingly popular for
minor painful procedures.
Breastfeeding reduces pain response
in neonates during minor painful
procedures30–34 and is the preferred
natural analgesic technique.35,36
Incorporating breastfeeding into
hospital protocols for painful
procedures has been difficult.37
Several obstacles have been identified
for incorporating nonpharmacologic
techniques into hospital pain
protocols, including the organizational
challenges of coordinating a
mother–baby–phlebotomist blood
draw, attitudes and lack of
knowledge about infant pain, and the
hospital culture’s high resistance to
change.37–39 Sucrose’s advantage is
that it can be prescribed like
a medication, ordered on preprinted
or standard nursery forms, and made
immediately available to babies
when mothers cannot breastfeed.
Recent survey data suggest that in
younger high-risk populations,
.60% of newborn babies are not
breastfed.40
We have previously used natural
warmth as an analgesic agent in
newborn pain studies, transmitted
through skin-to-skin contact,41 during
breastfeeding,30 and by use of
a radiant warmer,42 to overcome
these obstacles in providing pain
relief to newborns. The current study
aimed to determine whether the
combination of sucrose and radiant
warmth would decrease behavioral
and physiologic indicators of pain in
newborns undergoing a hepatitis




Participants were 29 healthy, full-
term newborns born at the University
of Chicago Hospital between July and
August 2008. Per hospital protocol,
consent for the hepatitis
B vaccination was obtained in the
delivery room. The hospital’s
preprinted newborn nursery orders
included sucrose taste as an
analgesic. Mothers in the general care
nursery who had previously
consented for the vaccination were
asked to participate. Consistent with
the hospital policy, mothers could
request to breastfeed as analgesic for
the procedure, but none did.
Exclusion criteria included preterm
birth (,37 weeks’ completed
gestation), birth weight ,2 kg, any
Apgar score ,6, congenital
abnormalities, medical complications,
or drug exposure. Infants with
previous oxygen administration,
ventilatory support, or NICU
admission were also excluded. Based
on our previous study,34 we
calculated that a sample size of
15 infants per group was necessary to
achieve a statistically reliable
reduction in grimacing and crying,
with a power of 80% and a P ,.05.
Table 1 shows demographic data. The
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University of Chicago institutional
review board approved this study,
and informed consent was obtained
from the parents of each infant.
Procedure
We randomly assigned each infant in
the study to sucrose alone or sucrose
plus warmer groups by using a sealed
envelope randomization system. All
hepatitis B vaccinations were given in
the general care nursery by a single
physician (L.G.) to minimize
variability. Infants in the warmer plus
sucrose group were placed under the
Ohmeda Ohio Infant Warmer (Model
No. 3000; GE Healthcare, Fairfield,
CT), and their clothing was removed,
except for a diaper. As a precaution
against overheating or overcooling,
infants were connected to the
warmer’s servo control and
temperature monitoring system at all
times. Infants in the sucrose alone
group rested quietly in their
bassinets, clothed in a diaper and
shirt and unswaddled for the
duration of the study. All infants had
3 neonatal electrocardiographic
(ECG) electrodes placed for heart rate
monitoring and intrascapular,
abdominal, and rectal temperature
probes for safety temperature
monitoring.
The study began once the infant
achieved a calm and drowsy state. We
controlled for behavioral state by
initiating the protocol after each
infant spontaneously reached 1 of
3 quiet behavioral states as defined
by Prechtl (State 1: eyes closed,
regular respiration, no movements;
State 2: eyes closed, irregular
respiration, small movements; or
State 3: eyes open, no movements).43
The protocol consisted of a baseline
period (5 minutes), intervention
(2 minutes), followed by the
vaccination (10 seconds), and
a recovery period (5 minutes). During
the baseline period, the infant’s face
was videotaped and the infant’s heart
rate was continuously recorded.
After 5 minutes, the intervention
period began. During the 2-minute
intervention period, infants in the
sucrose alone group were given
0.24 g of sucrose (1.0 mL of 24%
sucrose solution, Sweet-Ease; Philips
Children’s Medical Ventures,
Monroeville, PA). Infants in the
sucrose plus warmer group were
given 0.24 g of sucrose with the infant
warmer increased to create
a 0.5°C temperature gradient
between the baby and the radiant
warmth control temperature. The
infant warmer’s power is preset to
create a 0.5°C temperature difference
(100% power) and has an automatic
safety shutoff at 12 minutes, well
past this study’s 2-minute timed
radiant heat exposure.45 Each infant
received the recommended 1 mL
sucrose dose in accordance with the
Cochrane Systematic Review
recommendations of 0.2 to 0.5 mL/kg
for full-term infants for a single
procedure.3,19 After the 2-minute
intervention period, the infant’s
lateral thigh was swabbed with
alcohol, the intramuscular hepatitis
B immunization (Recombivax HB;
Merck & Co Inc, Whitehouse Station,
NJ) was administered via a 1-mL
Kendall Syringe with Safety Needle
(Covidien, Mansfield, MA), and an
adhesive bandage was applied. After
the vaccination, the radiant warmer
was returned to the automatic or
servo control setting. Heart rate,
temperature, and video recording
continued for 5 minutes after the
immunization.
Data Analysis
We assessed pain by using both
behavioral and physiologic indices.
The infant’s face was videotaped for
offline coding of grimace and cry. Two
research assistants not associated
with data collection were trained (by
L.G.) to record grimace as brow bulge,
eye squeeze, and nasolabial
furrowing, and they independently
coded each video. Both cry and
grimace were coded after the
vaccination was completed and
adhesive bandage applied. Facial
grimacing was scored continuously
from the video portion of the tape,
and crying was scored independently
from the audio portion with video
blank. Crying was scored
continuously as the presence of an
audible crying sound independent of
quality. Facial grimacing was scored
when brow bulging, eye squeezing,
and nasolabial furrowing occurred
simultaneously. These facial actions
have been reported in 99% of
neonates within 6 s of heel stick and
are believed to be very sensitive
indices of infant pain.45,46 Because
sleep state was controlled for at the
onset of the study, this allowed us to
focus on facial action as the most
sensitive behavioral indicator of
infant pain.47 Scorers were
uninformed as to experimental
condition when scoring cry from the
auditory portion of the tape. For
grimacing, the video camera was
focused on the infant’s face to record
facial actions only and prevent
accidental unblinding of subjects
during coding. The total amount of
time each infant spent grimacing or
crying throughout the study was
quantified. The level of grimacing
and crying was low in each group,
and the correlations between the
coders was high (r = 0.999 for
grimace; r = 0.998 for cry). Therefore,
we averaged the data from each coder
into a “master average” for all
analyses.
TABLE 1 Subject Characteristics
Characteristic n Mean (%) SD
Gestational age (wk) 39 0.6















Birth wt (g) 3202 316.9
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ECG data were digitized, and time
series of R–R intervals (time between
successive R-waves of the ECG) were
processed to quantify the amplitude
of respiratory sinus arrhythmia (RSA)
by Porges’ method.48,49 We derived
RSA from the edited R–R intervals by
using CardioBatch software
(Brain–Body Center, University of
Illinois, Chicago, IL). CardioBatch
applies a moving polynomial
filter50–52 and quantifies the
amplitude of RSA with age-specific
parameters, sensitive to the
maturational shifts in the frequency
of spontaneous breathing (0.3–1.3 Hz
for the neonate).52,53 Average heart
rate and the amplitude of RSA were
calculated in sequential 30-s epochs
in each condition (baseline,
intervention, and recovery). Data
were truncated to ensure that the last
6 30-s epochs before vaccination
were used for baseline, the first
6 30-s epochs after vaccination were
use for the vaccination condition, and
the subsequent 8 30-s epochs were
used for the recovery condition. The
means of the within-condition epochs
(baseline, vaccination, and recovery)
were used as a repeated measure for
heart rate and RSA. ECG data with
minimal recording artifact, sufficient
for data analyses, were available from
27 neonates (12 in the sucrose plus
warmer group and 15 in the sucrose
only group).
We analyzed data by using SPSS
16.0 (IBM SPSS Statistics, IBM
Corporation). Pillai’s trace
multivariate tests were used for
univariate repeated-measures
analyses of variance to evaluate heart
rate, RSA, and temperature during the
3 conditions of the experiment
(baseline, intervention, and recovery).
The multivariate analyses provide
a robust estimate of effects when the
repeated measures are
autocorrelated, as is the case with
heart rate, RSA, and temperature.
Because the distributions of both cry
and grimace deviated from normal,
nonparametric Kruskal–Wallis 1-way
analysis of variance by ranks was
used to compare group differences.
Interrater reliability for ranks
approached 1.0, and the average rank
for each participant was used in the
Kruskal–Wallis analyses.
RESULTS
The sucrose plus warmer group cried
and grimaced for 50% less time after
the vaccination than the sucrose
alone group (P , .05, respectively).
Infants in the sucrose plus warmer
group (n = 14) cried and grimaced on
average 12.8 and 14.9 seconds,
respectively. Infants who received
sucrose alone (n = 15) cried and
grimaced on average for 28.0 and
31.1 seconds, respectively. Figure 1
illustrates the cry and grimace
durations for each group. Cry and
grimace durations were significantly
shorter in the sucrose plus warmer
group than in the sucrose alone group
(P , .05, Kruskal–Wallis test). The
standard deviations for each variable
within each group were noticeably
greater in the sucrose group for cry
(eg, 6.9 seconds vs 2.2 seconds) and
grimace (eg, 7.2 seconds vs 2.4
seconds). The correlation between
the latencies of the 2 variables
approached unity (ie, .0.975).
Elevation of heart rate and
suppression of RSA were used as
physiologic indicators of pain. Heart
rate and RSA data across the
3 conditions (baseline, vaccination,
and recovery) were available for
15 neonates in the sucrose-only
group and 12 neonates in the sucrose
plus warmer group. Analyses of
variance contrasted the mean heart
rate and RSA between the groups
during the 3 conditions of the
experiment. Analyses of variance
documented significant condition
effects for both heart rate (P , .001)
and RSA (P , .001) and a significant
group 3 condition interaction for
RSA (P , .02). As illustrated in Figs 2
and 3, heart rate increased and
RSA decreased in response to the
vaccination. Focusing on the
reactivity to the vaccination, group by
repeated measure analyses of
variance were conducted on the
baseline and vaccination conditions.
These analyses indicated that the
sucrose only group reacted to the
vaccination with significantly greater
increases in heart rate (P , .02) and
greater decreases in RSA (P , .03).
Heart rate increased approximately
20 beats per minute for the sucrose-
only group and about 11 beats per
minute for the sucrose plus warmer
group. Similarly, RSA decreased
approximately 1.83 (natural log
units) for the sucrose only group and
FIGURE 1
Cry and grimace durations. Durations were coded after completion of the vaccination. Infants in the
sucrose plus warmer group cried for significantly less time (P , .05, Kruskal–Wallis test) and
grimaced significantly less than infants in the sucrose alone group (P , .05, Kruskal–Wallis test).
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about 0.65 (natural log units) for the
sucrose plus warmer group. The
behavioral and autonomic indices of
reactivity to the vaccination were
moderately correlated. Across both
groups, the duration of grimacing was
significantly correlated with increases
in heart rate (r = 0.531, P , .004)
and decreases in RSA (r = 20.454,
P , .017). Similarly, across groups,
the duration of crying was
significantly correlated with increases
in heart rate (r = 0.529, P , .005) and
decreases in RSA (20.437, P , .02).
Rectal temperatures did not differ
between the groups throughout the
study period. Mean rectal
temperature6 SEM was 36.66 0.09°C
for the sucrose and warmer group
and 36.5 6 0.08°C for the sucrose
alone group, P = .44.
DISCUSSION
Sucrose is widely used in pain relief
for newborns during minor painful
procedures. Based on our previous
work,30,41 including data on thermal
analgesia,42 we have demonstrated
that the transmission of warmth is
1 component of breastfeeding that
protects the infant during a painful
experience. In this study, we showed
that the combination of sucrose and
radiant warmth before a hepatitis B
vaccination reduced both physiologic
and behavioral indicators of pain in
newborns better than sucrose alone.
The sucrose plus warmer group had
consistently lower mean crying and
grimace times after the vaccination
compared with infants in the sucrose
alone group. As illustrated in Figs 2
and 3, the sucrose plus warmer group
also reacted with a dampened
autonomic reaction (eg, less heart
rate acceleration and RSA reduction)
from baseline to the vaccination than
the sucrose alone group. The
differences in both behavioral and
physiologic indices of pain indicate
that radiant warmth enhanced the
analgesic effects of sucrose.
We believe that the dampened heart
rate and behavioral reactivity to the
vaccination observed in the sucrose
plus warmer group has clinical
significance. The sucrose plus
warmer group showed almost no
reduction in RSA in response to the
pain procedure, compared with the
large drop observed in the sucrose
alone group. The observed drop in
RSA represents a significant
decrease in the vagal regulation of
the heart. Vagal efferent pathways
regulate heart rate by acting as
a “brake” on the sinoatrial node. In
response to an environmental
challenge, cardiac vagal tone
decreases to increase cardiac output
to respond to the painful
challenge.48 Infants in the sucrose
plus warmer group were able to
maintain a higher RSA during the
vaccination. Higher RSA in the
sucrose plus warmer group reflects
a more optimal ability to
physiologically self-regulate during
the stressful parts of vaccination.54
In contrast, the sucrose alone group
had a marked decrease in RSA
during the stressful parts of the
study. This, we believe, was evidence
of poor physiologic self-regulation
during the stress of vaccination.
One limitation of this study is the
choice of our pain assessment tool.
With .30 different pain scales
available and none demonstrating
clear superiority, we decided to focus
on the most sensitive behavioral and
physiologic indicators of infant pain
by using crying, facial grimacing,
and changes in heart rate. In fact,
a recent comparison of pain
assessment tools indicates that these
behavioral and physiologic features
FIGURE 2
Heart rate during protocol. The sucrose plus warmer group had dampened heart rate acceleration
to the vaccination, F(1, 25) = 6.1, P , .02.
FIGURE 3
RSA. The sucrose plus warmer group had a dampened suppression of RSA in response to the
vaccination, F(2, 50) = 4.12, P , .02.
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are more sensitive in identifying
infant pain than a multidimensional
pain assessment tool.55 Our data
support this decision: Both groups of
infants showed significant
correlations between their behavioral
indicators of pain (duration of
crying and grimacing) with their
physiologic response to the pain
(increases in heart rate). Second, in
this study we collected safety
temperature monitoring with rectal
temperature probes. Here, as in our
previous study,42 a 2-minute
exposure to increased natural
warmth did not alter the infant’s core
temperature. These data support the
use of warmers for short periods
without ongoing monitoring of rectal
temperatures. However, these data
do not indicate the optimal
temperature gradient for analgesic
effectiveness or the time period that
may affect core temperatures.
Finally, our small sample size may
have introduced the risk of a type
1 error.
This study adds to the growing
literature on natural calming
techniques to combat infant pain.
The use of sucrose as an analgesic
for newborns undergoing routine,
minor painful procedures is part of
many hospitals’ existing pain
protocols. This study demonstrates
that adding natural warmth to this
widely used technique confers
additional pain-relieving benefits to
the infant while adding little or no
additional cost or effort. Ultimately,
knowledge gained from this study
may allow health care providers to
examine their current practice and
incorporate more or all of the
components of maternal
breastfeeding into their minor
procedure pain management
strategies for the newborn.
Encouraging breastfeeding in the
newborn nursery and keeping the
mother and healthy infant together is
an increasingly important priority
for the health care provider. When
breastfeeding is not possible,
however, this study adds another
natural nonpharmacologic analgesic
technique for health care providers
to protect the newborn from the pain
of a routine immunization needle
stick. Additional studies examining
the use of this practical and
nonpharmacologic technique in
combination with nonsucrose
natural analgesic techniques, such
as pacifier suckling, and with
different populations of newborn
infants are needed.
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